Novo Nordisk A/S (NVO) Stock Analysis

Novo Nordisk A/S (NVO) is a publicly traded company in the HEALTHCARE sector. It trades at $44.07, carries a market capitalization of $201.95B, a price-to-earnings ratio of 10.70, a dividend yield of 0.04%. This page summarizes the public market data, fundamentals, and frequently asked questions for NVO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NYSE

Key Metrics

Market Sentiment

Novo Nordisk A/S currently has a Bullish sentiment score of 0.38.

About Novo Nordisk A/S

Novo Nordisk A/S (NVO) is a premier global healthcare company headquartered in Bagsvaerd, Denmark, renowned for its expertise in diabetes care, obesity treatment, and hormone replacement therapies. The company stands at the forefront of innovation, utilizing advanced biotechnology and rigorous scientific research to develop and manufacture high-quality pharmaceutical products aimed at chronic disease management. As a leader in the biopharmaceutical sector, Novo Nordisk is dedicated to enhanci...

GNG Research Analysis

GNG Research scores Novo Nordisk A/S (NVO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NVO.

Frequently Asked Questions

What is NVO's current dividend yield?

Novo Nordisk A/S (NVO) has a current dividend yield of 0.04%.

Does NVO pay dividends?

Yes, Novo Nordisk A/S pays dividends with a current yield of 0.04%.

What is NVO's P/E ratio?

Novo Nordisk A/S has a price-to-earnings (P/E) ratio of 10.70.

What is NVO's market cap?

Novo Nordisk A/S (NVO) has a market capitalization of $201.95B with a current stock price of $44.07.